Loading...

Shineco, Inc.

TYHTNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$11.09
$-0.45(-3.90%)
U.S. Market opens in 7h 10m

Shineco, Inc. Fundamental Analysis

Shineco, Inc. (TYHT) shows moderate financial fundamentals with a PE ratio of -10.40, profit margin of -5.42%, and ROE of -65.30%. The company generates $0.0B in annual revenue with strong year-over-year growth of 16.81%.

Key Strengths

PEG Ratio-0.10

Areas of Concern

ROE-65.30%
Operating Margin-2.07%
Cash Position0.11%
Current Ratio0.72
We analyze TYHT's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -431.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-431.6/100

We analyze TYHT's fundamental strength across five key dimensions:

Efficiency Score

Weak

TYHT struggles to generate sufficient returns from assets.

ROA > 10%
-19.58%

Valuation Score

Excellent

TYHT trades at attractive valuation levels.

PE < 25
-10.40
PEG Ratio < 2
-0.10

Growth Score

Moderate

TYHT shows steady but slowing expansion.

Revenue Growth > 5%
16.81%
EPS Growth > 10%
-2.03%

Financial Health Score

Moderate

TYHT shows balanced financial health with some risks.

Debt/Equity < 1
0.11
Current Ratio > 1
0.72

Profitability Score

Weak

TYHT struggles to sustain strong margins.

ROE > 15%
-6530.50%
Net Margin ≥ 15%
-5.42%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is TYHT Expensive or Cheap?

P/E Ratio

TYHT trades at -10.40 times earnings. This suggests potential undervaluation.

-10.40

PEG Ratio

When adjusting for growth, TYHT's PEG of -0.10 indicates potential undervaluation.

-0.10

Price to Book

The market values Shineco, Inc. at 9.58 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

9.58

EV/EBITDA

Enterprise value stands at -35.52 times EBITDA. This is generally considered low.

-35.52

How Well Does TYHT Make Money?

Net Profit Margin

For every $100 in sales, Shineco, Inc. keeps $-5.42 as profit after all expenses.

-5.42%

Operating Margin

Core operations generate -2.07 in profit for every $100 in revenue, before interest and taxes.

-2.07%

ROE

Management delivers $-65.30 in profit for every $100 of shareholder equity.

-65.30%

ROA

Shineco, Inc. generates $-19.58 in profit for every $100 in assets, demonstrating efficient asset deployment.

-19.58%

Following the Money - Real Cash Generation

Operating Cash Flow

Shineco, Inc. generates strong operating cash flow of $10.61M, reflecting robust business health.

$10.61M

Free Cash Flow

Shineco, Inc. generates strong free cash flow of $11.13M, providing ample flexibility for dividends, buybacks, or growth.

$11.13M

FCF Per Share

Each share generates $0.54 in free cash annually.

$0.54

FCF Yield

TYHT converts 3.69% of its market value into free cash.

3.69%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-10.40

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.10

vs 25 benchmark

P/B Ratio

Price to book value ratio

9.58

vs 25 benchmark

P/S Ratio

Price to sales ratio

74.16

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.11

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.72

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.65

vs 25 benchmark

ROA

Return on assets percentage

-0.20

vs 25 benchmark

ROCE

Return on capital employed

-0.17

vs 25 benchmark

How TYHT Stacks Against Its Sector Peers

MetricTYHT ValueSector AveragePerformance
P/E Ratio-10.4028.81 Better (Cheaper)
ROE-65.30%643.00% Weak
Net Margin-541.82%-44312.00% (disorted) Weak
Debt/Equity0.110.36 Strong (Low Leverage)
Current Ratio0.724.50 Weak Liquidity
ROA-19.58%-17799.00% (disorted) Weak

TYHT outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Shineco, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-94.25%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-616.48%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-120.58%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ